Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000943566 | SCV001089516 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489271 | SCV002802575 | likely benign | Autosomal dominant Alport syndrome; Autosomal recessive Alport syndrome; Benign familial hematuria | 2022-04-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001827009 | SCV002076401 | likely benign | Alport syndrome | 2020-01-19 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003933223 | SCV004747625 | likely benign | COL4A3-related disorder | 2019-07-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |